Browsing by Author "Delman, Murat"

Now showing 1 - 2 of 2

The investigation of anticancer properties of (R)-4'-methylklavuzon in liver cancer cells and liver cancer stem cells
(Izmir Institute of Technology, 2017-12) Delman, Murat; Çağır, Ali; Erdal, Esra
Hepatocellular carcinoma (HCC) is the fifth most seen cancer type and the third leading cause of death from cancers. HCC is a fatal disease and HCC patients have a 5-year survival rate of 14%. Discovery and identification of mechanisms of action for new therapeutic agents are required for a better treatment of HCC. One of the most important target in cancer treatment is the epigenetic acetylation of histones. Histone deacetylases (HDAC) and sirtuins provide chromatin compaction and transcriptional repression by removing acetyl groups from histone proteins and nonhistone proteins. Re-acetylation of chromatin and re-expression of tumor suppressor genes with the discovery of novel HDAC and/or sirtuin inhibitors are therapeutic targets in cancer research. In this study, (R)-4’-methylklavuzon was found to be cytotoxic in HuH-7 cells with IC50 values of 1.25 μM for HuH-7 parental cells, 2.5 μM for EpCAM+/CD133+ HuH-7 cells and 1.25 μM for EpCAM-/CD133- HuH-7 cells. It was observed that (R)-4’-methylklavuzon causes cell cycle arrest at G1 phase at 1.00 μM concentration in three cell populations, it induces apoptosis at 10 μM concentration at the end of 24 hours incubation. (R)-4’-methylklavuzon does not inhibit Class I/II HDACs in vitro whereas it causes inhibition of endogenous HDACs and/or sirtuins inside the cells sorted by MACS and FACS at 0.10 μM concentration. (R)-4’-methylklavuzon upregulates p21 expression significantly in HuH-7 cell populations to cause G1 arrest. It causes 45% inhibition in p53/MDM2 complex formation when examined with pure p53 and MDM2 proteins. Drug candidate causes 46% SIRT1 inhibition at 100 μM concentration in vitro whereas there was no inhibition of HDAC1 enzyme at the same concentration. SIRT1 protein levels in HuH-7 parental cells were upregulated to 240% within 24 hours of incubation with 3.00 μM of drug candidate. It was found that (R)-4’-methylklavuzon can also inhibit CRM1 protein providing increased retention of tumor suppressor proteins in the nucleus. p53 was overexpressed at 0.10 and 1.00 μM concentrations within 6 and 24 hours in HepG2 cells but slightly overexpressed in HuH-7 parental cells.
Molecular analysis of mammalian Neu4 sialidase gene promoter
(Izmir Institute of Technology, 2011) Delman, Murat; Seyrantepe, Volkan
There are four different mammalian sialidases that have been described; lysosomal (Neu1), cytoplasmic (Neu2), plasma membrane (Neu3), lysosomal/mitochondrial (Neu4). The activity of sialidase Neu4 enzyme against sialic acid containing ganglioside GM2 has been demonstrated. Biological role of sialidase Neu4 enzyme has been shown by the transfection of neuroglia cells from a Tay-Sachs patient with a Neu4-expressing plasmid showed clearance of accumulated ganglioside GM2. It has been also shown that sialidase Neu4 enzyme is responsible for degradation reactions of another ganglioside such as GD1a in brains of Neu4-/- mice. Aim of our study is to identify minimal promoter region of human Neu4 gene and demonstrate binding of transcription factors to this region. In our study, we used bioinformatic approaches to predict the sequence motifs where several specific transcription factors bind using TESS (Transcription Element Seach System) tool. We amplified seven different DNA fragments from human Neu4 promoter region, cloned into luciferase expression vector and performed reporter assay. We also performed electrophoretic mobility shift assay to demonstrate binding of transcription factors to candidate promoter region. We demonstrated that 187 bp upstream of Neu4 gene is minimal promoter region to control transcription from Neu4 gene. Electrophoretic mobility shift assay showed that 187 bp upstream region recruits several transcription factors. Our results demonstrated the minimal promoter region revealing several putative transcription factors such as Sp-1 and c-myc which might be responsible mainly for regulation of Neu4 gene transcription. The data we obtained might be useful to discover small molecules which can control Neu4 gene expression. High expression of Neu4 gene might be controlled using drugs or small molecules and the accumulated GM2 ganglioside in lysosomes of Tay-Sachs patients can be reduced.